Nasal polyposis represents the end point of multiple inflammatory pathways and controversy continues as to the exact roles of medical and surgical approaches in the management of nasal polyposis.
Methods
A combination of both is often required to manage polyps adequately with surgery and intranasal steroids remaining the mainstay of therapy.
Results
Fortunately, new technological advances are making surgery safer and more efficient. In the postoperative period, debridement is effective in reducing the formation of adhesions, and topical medications may play a beneficial role in preventing polyp reformation.
Conclusion
Additional investigations into the optimal perioperative medical management is needed to ensure optimal surgical outcomes.
Get full access to this article
View all access options for this article.
References
1.
LanzaD.C., and KennedyD.W.Adult rhinosinusitis defined.Otolaryngol Head Neck Surg117: S1, 1997.
2.
BenningerM.S., FergusonB.J., HadleyJ.A.Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology.Otolaryngol Head Neck Surg129: S1, 2003.
3.
MeltzerE.O., HamilosD.L., HadleyJ.A.Rhinosinusitis: Establishing definitions for clinical research and patient care.J Allergy Clin Immunol114: 155, 2004.
4.
FokkensW., LundV., BachertC.EAACI position paper on rhinosinusitis and nasal polyps executive summary.Allergy60: 583, 2005.
5.
ScaddingG.K., DurhamS.R., MirakianR.BSACI guidelines for the management of rhinosinusitis and nasal polyposis.Clin Exp Allergy38: 260, 2008.
6.
HamilosD.L.Chronic rhinosinusitis patterns of illness.Clin Allergy Immunol20: 1, 2007.
7.
BhattacharyyaN.Clinical and symptom criteria for the accurate diagnosis of chronic rhinosinusitis.Laryngoscope116(suppl 110): 1–22, 2006.
8.
MygindN., DahlR., and BachertC.Nasal polyposis, eosinophil dominated inflammation, and allergy.Thorax55(suppl): S79–S83, 2000.
9.
HamilosD.L.Nasal polyps as immunoreactive tissue.Allergy Asthma Proc17: 293, 1996.
10.
BatemanN., FahyC., and WoolfordT.Nasal polyps: Still more questions than answers.J Laryngol Otol117: 1–9, 2003.
SettipaneG.A.Epidemiology of nasal polyps.In Nasal Polyps: Epidemiology, Pathogenesis and Treatment. SettipaneG.A., LundV.J., BernsteinJ.M., and TosM. (Eds.). Providence, RI: OceanSide Publications, 17–24, 1997.
13.
LarsenP., and TosM.Origin of nasal polyps: An endoscopic autopsy study.Laryngoscope114: 710–719, 2004.
14.
LarsenK., and TosM.The estimated incidence of symptomatic nasal polyps.Acta Otolaryngol122: 179–182, 2002.
15.
BeckerS.S.Surgical management of polyps in the treatment of nasal airway obstruction.Otolaryngol Clin North Am42: 377–385, 2009.
16.
NorlanderT., WestrinK., FukamiM.Experimentally induced polyps in the sinus mucosa: A structural analysis in the initial stages.Laryngoscope106: 196–203, 1996.
17.
RamanathanM., LeeW., SpannhakeE.Th2 cytokines associated with chronic rhinosinusitis with polyps down-regulate the antimicrobial immune function of human sinonasal epithelial cells.Am J Rhinol22: 115–121, 2008.
18.
RamanathanM., LeeW., DubinM.Sinonasal epithelial cell expression of toll-like receptor 9 is decreased in chronic rhinosinusitis with polyps.Am J Rhinol21: 110–116, 2007.
19.
LaneA., Truong-Tran Q, and Schleimer R. Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps.Am J Rhinol20: 138–144, 2006.
20.
QiuZ., HanD., ZhangL.Expression of survivin and enhanced polypogenesis in nasal polyps.Am J Rhinol22: 106–110, 2008.
21.
KowalskiM., GrzegorczykJ., PawliczakR.Decreased apoptosis and distinct profile of infiltrating cells in the nasal polyps of patients with aspirin hypersensitivity.Allergy57: 493–500, 2002.
22.
MeyerJ.E., Bartels J, Gorogh T, et al. The role of RANTES in nasal polyposis.Am J Rhinol19: 15–20, 2005.
23.
OlzeH., ForsterU., ZuberbierT.Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3.Rhinology44: 145–150, 2006.
24.
RudackC., StollW., and BachertC.Cytokines in nasal polyposis, acute and chronic sinusitis.Am J Rhinol12: 383–388, 1998.
25.
OhoriJ., UshikaiM., SunD.TNF-alpha upregulates VCAM-1 and NF-kappa B in fibroblasts from nasal polyps.Auris Nasus Larynx34: 177–183, 2007.
26.
KimT., LeeS., LeeH.D2–40 immunohistochemical assessment of lymphangiogenesis in normal an edematous sinus mucosa and nasal polyp.Laryngoscope117: 442–446, 2007.
27.
Lechapat-ZalcmanE., CosteA., D'OrthoM.Increased expression of matrix metalloproteinase-9 in nasal polyps.J Pathol193: 233–241, 2001.
28.
BernsteinJ., and KansalR.Superantigen hypothesis for the early development of chronic hyperplastic sinusitis with massive nasal polyposis.Curr Opin Otolaryngol Head Neck Surg13: 39–44, 2005.
29.
Van ZeleT., GevaertP., WateletJ.B.Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis.J Allergy Clin Immunol114: 981–983, 2004.
30.
CannadyS., BatraP., LeahyR.Signal transduction and oxidative processes in sinonasal polyposis.J Allergy Clin Immunol120: 1346–1353, 2007.
31.
BadiaL., and LundV.Topical corticosteroids in nasal polyposis.Drugs.61: 573–578, 2001.
32.
FillaciF., PassaliD., PuxedduR.A randomized controlled trial showing efficacy of once daily intranasal budesonide in nasal polyposis.Rhinology38: 185–190, 2000.
BonfilsP., NoresJ.M., HalimiP., and AvanP.Corticosteroid treatment in nasal polyposis with a three-year follow-up period.Laryngoscope.113: 683–687, 2003.
35.
JoeS.A., ThambiR., and HuangJ.A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis.Otolaryngol Head Neck Surg139: 340–347, 2008.
36.
AlbuS., GoceaA., and MitreI.Preoperative treatment with topical corticoids and bleeding during primary endoscopic sinus surgery.Otolaryngol Head Neck Surg143: 573–578, 2010 Oct.
37.
DesrosiersM., HussainA., FrenkielS.Intranasal corticosteroid use is associated with lower rates of bacterial recovery in chronic rhinosinusitis.Otolaryngol Head Neck Surg136: 605–609, 2007.
38.
AukemaA.A., MulderP.G., and FokkensW.J.Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery.J Allergy Clin Immunol115: 1017–1023, 2005.
39.
Rowe-JonesJ.M., MedcalfM., DurhamS.R.Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomized, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray.Rhinology43: 2–10, 2005.
40.
HartwigS., LindenM., LaurentC.Budesonide nasal spray as prophylactic treatment after polypectomy (a double blind clinical trial).J Laryngol Otol102: 148–151, 1988.
41.
DingsorG., KramerJ., OlsholtR., and SoderstromT.(1985) Flunisolide nasal spray 0.025% in the prophylactic treatment of nasal polyposis after polypectomy. A randomized, double blind, parallel, placebo controlled study.Rhinology23: 49–58, 1985.
42.
KarlssonG., and RundcrantzH.A randomized trial of intranasal beclomethasone dipropionate after polypectomy.Rhinology20: 144–148, 1982.
43.
Rowe JonesJ.M., MedcalfM., DurhamS.R.Functional endoscopic sinus surgery: 5 year follow up and results of a prospective randomized double-blind placebo controlled trial of post-operative fluticasone propionate nasal spray.Rhinology43: 2–10, 2005.
44.
KennedyD.W., ZinreichS.J., RosenbaumA.E.Functional endoscopic sinus surgery: Theory and diagnostic evaluation. Arch.Otolaryngol.111: 576–582, 1985.
45.
KayarkerR., CliftonN.J., and WoolfordT.J.An evaluation of the best head position for instillation of steroid nose drops.Clin Otolaryngol27: 18–21, 2002.
46.
BadiaL., and LundV.Topical corticosteroids in nasal polyposis.Drugs61: 573–578, 2001.
47.
GazisA.G., HomerJ.J., HensonD.B.The effect of six weeks topical nasal betamethasone drops on the hypothalamo-pituitary-adrenal axis and bone turnover in patients with nasal polyposis.Clin Otolaryngol24: 495–498, 1999.
48.
StevensD.J.Cushing's syndrome due to abuse of betamethasone drops.J Laryngol Otol102: 219–221, 1988.
49.
HomerJ.J., and GazisT.G.Cushing's syndrome induced by betamethasone nasal drops.BMJ318: 1355, 1999.
50.
KeithP., NieminenJ., HollingworthK.Efficacy and tolerability of fluticasone propionate nasal drops 400 mgs once daily compared with placebo for the treatment of bilateral polyposis in adults.Clin Exp Allergy30: 1460–1468, 2000.
51.
PentilaM., PoulsenP., HollingworthK.Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 mg once daily and twice daily in the treatment of bilateral nasal polyposis: A placebo-controlled, randomised study in adult patients.Clin Exp Allergy30: 94–102, 2000.
52.
BruniF.M., De LucaJ., VenturoliV.Intranasal corticosteroids and adrenal suppression.Neuroimmunomodulation16: 353–362, 2009.
53.
HansenF.S., DjupeslandP.G., and FokkensW.J.Preliminary efficacy of fluticasone delivered by a novel device in recalcitrant chronic rhinosinusitis.Rhinology48: 292–299, 2010.
54.
BakerJ.W., MellonM., WaldJ.A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants.Pediatrics103: 414–421, 1999.
55.
KempJ.P., SkonerD.P., SzeflerS.J.Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children.Ann Allergy Asthma Immunol83: 231–239, 1999.
56.
ShapiroG.G., MendelsonL.M., and PearlmanD.S.Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.Ann Allergy Asthma Immunol86: 633–640, 2001.
57.
ReidA., MurphyC., SteenH.J.Linear growth of very young asthmatic children treated with high-dose nebulized budesonide.Acta Paediatr85: 421–424, 1996.
58.
MurphyK., UryniakT., SimpsonB.Growth velocity in children with perennial allergic rhinitis treated with budesonide aqueous nasal spray.Ann Allergy Asthma Immunol96: 723–730, 2006.
59.
AgertoftL., and PedersenS.Effect of long-term treatment with inhaled budesonide on adult height in children with asthma.N Engl J Med343: 1064–1069, 2000.
60.
PauwelsR.A., PedersenS., BusseW.W.START Investigators Group. Early intervention with budesonide in mild persistent asthma: A randomised, double-blind trial.Lancet361: 1071–1076, 2003.
61.
BhallaR.K., PaytonK., and WrightE.D.Safety of budesonide in saline sinonasal irrigations in the management of chronic rhinosinusitis with polyposis: Lack of significant adrenal suppression.J Otolaryngol Head Neck Surg37: 821–825, 2008.
62.
WelchK.C., ThalerE.R., DoghramjiL.L.The effects of serum and urinary cortisol levels of topical intranasal irrigations with budesonide added to saline in patients with recurrent polyposis after endoscopic sinus surgery.Am J Rhinol Allergy24: 26–28, 2010.
63.
SachanandaniN.S., PiccirilloJ.F., KramperM.A.The effect of nasally administered budesonide respules on adrenal cortex function in patients with chronic rhinosinusitis.Arch Otolaryngol Head Neck Surg135: 303–307, 2009.
64.
AntunesM.B., and BeckerS.S.The role of local steroid injection for nasal polyposis.Curr Allergy Asthma Rep10: 175–180, 2010.
65.
LildholdtT., RundcrantzH., BendeH.Glucocorticoid treatment for nasal polyps: The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment.Arch Otolaryngol Head Neck Surg123: 595–600, 1997.
66.
HissariaP., SmithW., WormaldP.J.Short course of systemic corticosteroids in sinonasal polyposis: A double-blind, randomized, placebo-controlled trial with evaluation of outcome measures.J Allergy Clin Immunol118: 128–133, 2006.
67.
LildholtT., DahlR., and MygindN.Effect of corticosteroids. Evidence from controlled trials. In Nasal Polyposis: An Inflammatory Disease and Its Treatment.MygindN., and LindholtT. (Eds). Copenhagen, Denmark: Munksgaard, 160–169, 1997.
68.
Van CampP., and ClementP.Results of oral steroid treatment in nasal polyposis.Rhinology32: 5–9, 1994.
69.
Heden BlomqvistE., LundbladL., AnggardA.A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis.J Allergy Clin Immunol107: 224–228, 2001.
70.
WrightE.D., and AgrawalS.Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: Evaluation with the novel perioperative sinus endoscopy (POSE) scoring system.Laryngoscope117(suppl 115): 1–28, 2007.
71.
SieskiewiczA., OlszewskaE., RogowskiM.Preoperative corticosteroid oral therapy and intraoperative bleeding during functional endoscopic sinus surgery in patients with severe nasal polyposis: A preliminary investigation.Ann Otol Rhinol Laryngol115: 490–494, 2006.
72.
KanowitzS.J., BatraP.S., and CitardiM.J.Topical budesonide via mucosal atomization device in refractory postoperative chronic rhinosinusitis.Otolaryngol Head Neck Surg139: 131–136, 2008.
73.
IinoY., SasakiY., KojimaC.Effect of macrolides on the expression of HLADR and costimulatory molecules on antigen- presenting cells in nasal polyps.Ann Otol Rhinol Laryngol110: 457–463, 2001.
74.
RagabS.M., LundV.J., and ScaddingG.K.Evaluation of medical and surgical treatment of chronic rhinosinusitis: A prospective randomised, controlled trial.Laryngoscope114: 923–930, 2004.
75.
WallworkB., ComanW., Mackay-SimA.A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis.Laryngoscope116: 189–193, 2006.
76.
WallworkB., ComanW., FeronF.Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis.Laryngoscope112: 1827–1830, 2002.
77.
DesrosiersM., and Salas-PratoM.Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: Results of a controlled trial.Otolaryngol Head Neck Surg125: 265–269, 2001.
78.
GoossensH., FerechM., Vander SticheleR., and ElseviersM.Outpatient antibiotic use in Europe and association with resistance: A cross-national database study.Lancet365: 579–587, 2005.
79.
PonikauJ.U., SherrisD.A., KernE.B.The diagnosis and incidence of allergic fungal sinusitis.Mayo Clin Proc74: 877–884, 1999.
80.
RicchettiA., LandisB.N., MaffioliA.Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis.J Laryngol Otol116: 261–263, 2002.
81.
GerlingerI., FittlerA., FónaiF.Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy.Eur Arch Otorhinolaryngol266: 847–855, 2009.
82.
HelblingA., BaumannA., HanniC.Amphotericin B nasal spray has no effect on nasal polyps.J Laryngol Otol.120: 1023–1025, 2006.
83.
WeschtaM., RimekD., FormanekM.Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: A randomized, double-blind clinical trial.J Allergy Clin Immunol113: 1122–1128, 2004.
84.
ParnesS.M., and ChumaA.V.Acute effects of antileukotrienes on sinonasal polyposis and sinusitis.Ear Nose Throat J79: 18–21, 24–25, 2000.
85.
DahlenB., NizankowskaE., SzczeklikA.Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.Am J Respir Crit Care Med157: 1187–1194, 1998.
86.
BernsteinJ.M., BallowM., SchlievertP.M.A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis.Am J Rhinol17: 321–326, 2003.
87.
McMainsK.C., and KountakisS.E.Medical and surgical considerations in patients with Samter's triad.Am J Rhinol20: 573–576, 2006.
88.
RozasasiA., PolzehlD., DeutschleT.Long-term treatment with aspirin desensitization: A prospective clinical trial comparing 100 and 300 mg aspirin daily.Allergy63: 1228–1234, 2008.
89.
StevensonD., HankammerM., MathisonD.Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: Long-term outcomes.J Allergy Clin Immunol98: 751–758, 1996.
90.
ParikhA.A., and ScaddingG.K.Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: A controlled trial.Laryngoscope115: 1385–1390, 2005.
91.
HayeR., AanesenJ., BurtinB.The effect of cetirizine on symptoms and signs of nasal polyposis.J Laryngol Otol112: 1042–1046, 1998.
92.
KroflicB., CoerA., BaudoinT.Topical furosemide versus oral steroid in preoperative management of nasal polyposis.Eur Arch Otorhinolaryngol263: 767–771, 2006.
93.
PassaliD., BernsteinJ.M., PassaliF.M.Treatment of recurrent chronic hyperplastic sinusitis with nasal polyposis.Arch Otolaryngol Head Neck Surg129: 656–659, 2003.
ZhengC., WangZ., and LacroixJ.S.Effect of intranasal treatment with capsaicin on the recurrence of polyps after polypectomy and ethmoidectomy.Acta Otolaryngol.120: 62–66, 2000.
96.
HarveyR., HannanS.A., BadiaL.Nasal saline irrigations for the symptoms of chronic rhinosinusitis.Cochrane Database Syst Rev18: CD006394, 2007.
97.
CometR., DomingoC., LarrosaM.Benefits of low weekly doses of methotrexate in steroid-dependent asthmatic patients. A double-blind, randomized, placebo-controlled study.Respir Med100: 411–419, 2006.
98.
AsplundM.S., HagbergH., and HolmstromM.Chemotherapy in severe nasal polyposis—A possible beneficial effect? a report of three cases.Rhinology48: 374–376, 2010.
99.
BuyukozturkS., GelincikA., and AslanI.Methotrexate: Can it be a choice for nasal polyposis in aspirin exacerbated respiratory disease?J Asthma46: 1037–1041, 2009.
100.
VerbruggenK., Van CauwenbergeP., BachertC.Anti-IgE for the treatment of allergic rhinitis—And eventually nasal polyps?Int Arch Allergy Immunol148: 87–98, 2009.
101.
LildholdtT.Surgical versus medical treatment of nasal polyps.Rhinol Suppl8: 31–33, 1989.
102.
FokkensW., LundV., and MullolJ.European Position Paper on Rhinosinusitis and Nasal Polyps Group. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists.Rhinology45: 97–101, 2007.
103.
Rowe JonesJ.M., MedcalfM., DurhamS.R.Functional endoscopic sinus surgery: 5 year follow up and results of a prospective randomized double-blind placebo controlled trial of post-operative fluticasone propionate nasal spray.Rhinology43: 2–10, 2005.
104.
McFaddenE., KanyR.J., FinkJ., and ToohillR.Surgery for sinusitis and aspirin triad.Laryngoscope100: 1043–1046, 1990.
105.
LarsenK., and TosM.A long-term follow-up study of nasal polyp patients after simple polypectomies.Eur Arch Otorhinolaryngol Suppl1: S85–S88, 1997.
106.
DalzielK., SteinK., RoundA.Endoscopic sinus surgery for the excision of nasal polyps: A systematic review of safety and effectiveness.Am J Rhinol20: 506–519, 2006.
107.
TerrisM.H., and DavidsonT.M.Review of published results for endoscopic sinus surgery.Ear Nose Throat J73: 574–580, 1994.
108.
HopkinsC., BrowneJ.P., and LundV.The national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis.Clin Otolarygol31: 390–398, 2006.
109.
MastersonL., TanweerF., BueserT.Extensive endoscopic sinus surgery: Does this reduce the revision rate for nasal polyposis?Eur Arch Otorhinolaryngol267: 1557–1561, 2010.
110.
LeeJ.M., and ChiuA.G.Role of maximal endoscopic sinus surgery techniques in chronic rhinosinusitis.Otolaryngol Clin North Am43: 579–589, 2010.
111.
MusyP.Y., and KountakisS.E.Anatomic findings in patients undergoing revision endoscopic sinus surgery.Am J Otolaryngol25: 418–422, 2004.
112.
ChiuA.G., and VaughanW.C.Revision endoscopic frontal sinus surgery with surgical navigation.Otolaryngol Head Neck Surg130: 312–318, 2004.
113.
ChiuA.G.Osteitis in chronic rhinosinusitis.Otolaryngol Clin North Am38: 1237–1242, 2005.
114.
LeeJ.T., KennedyD.W., PalmerJ.N.The incidence of concurrent osteitis in patients with chronic rhinosinusitis: A clinicopathological study.Am J Rhinol20: 278–282, 2006.
115.
ChoS.H., MinH.J., HanH.X.CT analysis and histopathology of bone remodeling in patients with chronic rhinosinusitis.Otolaryngol Head Neck Surg135: 404–408, 2006.
116.
KennedyD.W., SeniorB.A., GannonF.H.Histology and histomorphometry of ethmoid bone in chronic rhinosinusitis.Laryngoscope108: 502–507, 1998.
117.
CohenM., KofonowJ., NayakJ.V.Biofilms in chronic rhinosinusitis: A review.Am J Rhinol Allergy23: 255–260, 2009.
118.
KiriheneR.K., ReesG., and WormaldP.The influence of the size of the maxillary sinus ostium on the nasal and sinus nitric oxide levels.Am J Rhinol16: 261–264, 2002.
119.
CatalanoP.J., and RoffmanE.J.Evaluation of middle meatal stenting after minimally invasive sinus techniques (MIST).Otolaryngol Head Neck Surg128: 875–881, 2003.
120.
KennedyD.W.Functional endoscopic sinus surgery: Concepts, surgical indications and instrumentation.In Diseases of the Sinuses: Diagnosis and Management.KennedyD.W., BolgerW.E., and ZinreichS.J. (Eds.). Hamilton, ON, Canada: BC Decker, 197–210, 2000.
121.
SetliffR.C.Minimally invasive sinus surgery. The rationale and the technique.Otolaryngol Clin North Am29: 115–130, 1996.
122.
ChoD., and HwangP.H.Results of endoscopic maxillary mega-antrostomy in recalcitrant maxillary sinusitis.Am J Rhinol22: 658–662, 2008.
123.
WoodworthB.A., ParkerR.O., and SchlosserR.J.Modified endoscopic medial maxillectomy for chronic maxillary sinusitis.Am J Rhinol20: 317–319, 2006.
124.
AlbuS., and TomescuE.Small and large middle meatus antrostomies in the treatment of chronic maxillary sinusitis.Otolaryngol Head Neck Surg131: 542–547, 2004.
125.
WeberR., DrafW., KeerlR.Osteoplastic frontal sinus surgery with fat obliteration: Technique and long term results using MRI in 82 operations.Laryngoscope110: 1037–1044, 2000.
126.
HardyJ.M., and MontgomeryW.W.Osteoplastic frontal sinusotomy: An analysis of 250 operations.Ann Otol Rhinol Laryngol85: 523–532, 1976.
127.
HahnS., PalmerJ.N., PurkeyM.T.Indications for external frontal sinus procedures for inflammatory sinus disease.Am J Rhinol Allergy23: 342–347, 2009.
128.
SmithT.L., StewartM.G., OrlandiR.R.Indications for image-guided sinus surgery: The current evidence.Am J Rhinol21: 80–83, 2007.
129.
JackmanA.H., PalmerJ.N., ChiuA.G.Use of intraoperative CT scanning in endoscopic sinus surgery: A preliminary report.Am J Rhinol22: 170–174, 2008.
130.
BatraP.S., KanowitzS.J., and CitardiM.J.Clinical utility of intraoperative volume computed tomography scanner for endoscopic sinonasal and skull base procedures.Am J Rhinol22: 511–515, 2008.
131.
DrafW.Endonasal micro-endoscopic frontal sinus surgery: The Fulda concept.Op Tech Otolaryngol Head Neck Surg2: 234–240, 1991.
132.
GrossW.E., GrossC.W., BeckerD.Modified transnasal endoscopic Lothrop procedure as an alternative to frontal sinus obliteration.Otolaryngol Head Neck Surg113: 427–434, 1995.
133.
AndersonP., and SindwaniR.Safety and efficacy of the endoscopic modified Lothropprocedure: A systematic review and meta-analysis.Laryngoscope119: 1828–1833, 2009.
134.
JankowskiR., PigretD., and DecroocqF.Comparison of functional results after ethmoidectomy and nasalization for diffuse and severe nasal polyposis.Acta Otolaryngol117: 601–608, 1997.
135.
JankowskiR., PigretD., DecroocqF.Comparison of radical (nasalisation) and functional ethmoidectomy in patients with severe sinonasal polyposis. A retrospective study.Rev Laryngol Otol Rhinol (Bord)127: 131–140, 2006.
136.
OrlandiR.R., and LanzaD.C.Is nasal packing necessary following endoscopic sinus surgery?Laryngoscope114: 1541–1544, 2004.
137.
FranklinJ.H., and WrightE.D.Randomized, controlled, study of absorbable nasal packing on outcomes of surgical treatment of rhinosinusitis.Am J Rhinol21: 214–217, 2007.
138.
CoteD.W., and WrightE.D.Triamcinolone-impregnated nasal dressing following endoscopic sinus surgery: A randomized, double-blind, placebo-controlled study.Laryngoscope120: 1269–1273, 2010.
139.
WormaldP.J., BoustredR.N., LeT.A prospective single-blind randomized controlled study of use of hyaluronic acid nasal packs in patients after endoscopic sinus surgery.Am J Rhinol20: 7–10, 2006.
140.
BerlucchiM., CastelnuovoP., VincenziA.Endoscopic outcomes of resorbable nasal packing after functional endoscopic sinus surgery: A multicenter prospective randomized controlled study.Eur Arch Otorhinolaryngol266: 839–845, 2009.
141.
SzczygielskiK., RapiejkoP., WojdasA.Use of CMC foam sinus dressing in FESS.Eur Arch Otorhinolaryngol267: 537–540, 2010.
142.
PletcherS.D., and GoldbergA.N.Treatment of recurrent sinonasal polyposis with steroid-infused carboxymethylcellulose foam.Am J Rhinol Allergy24: 451–453, 2010.
143.
StewartA.E., and VaughanW.C.Balloon sinuplasty versus surgical management of chronic sinusitis.Curr Allergy Asthma Rep10: 181–187, 2010.
144.
StankiewiczJ.Complications of endoscopic nasal surgery: Occurrence and treatment.Am J Rhinol1: 45–49, 1987.
145.
ChandraR., PalmerJ., TangsujaritthamT.Factors associated with failure of frontal sinusotomy in the early follow-up period.Otolaryngol Head Neck Surg131: 514–518, 2004.
146.
BednarskiK.A., and KuhnF.A.Stents and drug-eluting stents.Otolaryngol Clin North Am42: 857–866, 2009.
147.
KuhnF.A., and CitardiM.J.Advances in postoperative care following functional endoscopic sinus surgery.Otolaryngol Clin North Am30: 479–490, 1997.
148.
ShomanN., GherianiH., GlamerD.Prospective, double-blind, randomized trial evaluating patient satisfaction, bleeding, and wound healing using biodegradable synthetic polyurethane foam (NasoPore) as a middle meatal spacer in functional endoscopic sinus surgery.J Otolaryngol Head Neck Surg38: 112–118, 2009.
149.
ShikaniA.A new middle meatal antrostomy stent for functional endoscopic sinus surgery.Laryngoscope104: 638–641, 1994.
150.
LynchR.C.The technique of a radical frontal sinus operation which has given me the best results.Laryngoscope31: 1–5, 1921.
151.
NeelH., WhitakerJ., and LakeC.Thin rubber sheeting in frontal sinus surgery: Animal and clinical studies.Laryngoscope86: 524–536, 1976.
152.
FreemanS., and BlomE.Frontal sinus stents.Laryngoscope110: 1179–1182, 2000.
153.
RainsB.Frontal sinus stenting.Otolaryngol Clin North Am34: 101–110, 2001.
154.
WeberR., HochapfelF., and DrafW.Packing and stents in endonasal surgery.Rhinology38: 49–62, 2000.
155.
OrlandiR., and KnightJ.Prolonged stenting of the frontal sinus.Laryngoscope119: 190–192, 2009.
156.
DubinM., and KuhnF.Preservation of natural frontal sinus outflow in the management of frontal sinus osteomas.Otolaryngol Head Neck Surg134: 18–24, 2006.
157.
HosemannW., KuhnelT., HeldP.Endonasal frontal sinusotomy in surgicalmanagement of chronic sinusitis: A critical evaluation.Am J Rhinol11: 1–19, 1997.
158.
DubinM., and KuhnF.Endoscopic modified Lothrop (Draf III) with frontal sinus punches.Laryngoscope115: 1702–1703, 2005.
159.
HosemannW., SchindlerE., WiegrebeE.Innovative frontal sinus stent acting as a local drug-releasing system.Eur Arch Otorhinolaryngol260: 131–134, 2003.
160.
CatalanoP.J., ThongM., and GargV.The MicroFlow Spacer: A drug-eluting stent for the ethmoid sinus.Oper Tech Otolaryngol20: 108–113, 2009.
161.
HuvenneW., ZhangN., TijsmaE.Pilot study using doxycycline-releasing stents to ameliorate postoperative healing quality after sinus surgery.Wound Repair Regen16: 757–767, 2008.
162.
HerrmannB., CitardiM., VoglerG.A preliminary report on the effects of Paclitaxel-impregnated stents on sheep nasal mucosa.Am J Rhinol18: 119–124, 2004.
163.
SnidvongsK., ChaowanapanjaP., AeumjaturapatS.Does nasal irrigation enter paranasal sinuses in chronic rhinosinusitis?Am J Rhinol22: 483–486, 2008.
164.
HyoN., TakanoH., and HyoY.Particle deposition efficiency of therapeutic aerosols in the human maxillary sinus.Rhinology27: 17–26, 1989.
165.
ValentineR., AthanasiadisT., ThwinM.A prospective controlled trial of pulsed nasal nebulizer in maximally dissected cadavers.Am J Rhinol22: 390–394, 2008.
166.
HarveyR.J., GoddardJ.C., WiseS.K.Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation.Otolaryngol Head Neck Surg139: 137–142, 2008.
167.
GroblerA., WeitzelE.K., BueleA.Pre- and postoperative sinus penetration of nasal irrigation.Laryngoscope118: 2078–2081, 2008.
168.
CheniteA., ChaputC., WangD.Novel injectable neutral solutions of chitosan form biodegradable gels in situ.Biomaterials21: 2155–2161, 2000.
Di ColoG., ZambitoY., and ZainoC.Polymeric enhancers of mucosal epithelia permeability: Synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues.J Pharm Sci97: 1652–1680, 2008.
171.
IllumL.Nasal drug delivery: New developments and strategies.Drug Discov Today7: 1184–1189, 2002.
172.
IbbotsonS.H., BilslandD., CoxN.H.An update and guidance on narrowband ultraviolet Bphototherapy: A British photodermatology group workshop report.Br J Dermatol151: 283–297, 2004.
173.
KoreckA.I., CsomaZ., BodaiL.Rhinophototherapy: A new therapeutic tool for the management of allergic rhinitis.J Allergy Clin Immunol115: 541–547, 2005.
174.
TrehanM., and TaylorC.R.Low-dose excimer 308-nm laser for the treatment of oral lichen planus.Arch Dermatol140: 415–420, 2004.
175.
BellaZ., KadocsaE., KemenyL.Narrow-band UVB phototherapy of nasal polyps: Results of a pilot study.J Photochem Photobiol B100: 123–127, 2010.
